Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
Share This Page

Abstract

Does Nature through the Predetermined Patterns of Lung Cancer Metastases Provide Strong Evidence for the Existence of an Intrinsic "Lymphogenous Metastasis Selectivity Factor?"

Wilson I. B. Onuigbo

Colonization patterns in cancer have long been fascinating. As far back as 1879, a striking example was reported as “Case of unilateral cancer.” A century later by 1975, Ariel reported a patient with exclusively right-sided pigmented cancer. Fortunately, chance, led me to do research under Professor D. F. Cappell at the University Department of Pathology based at the Glasgow Western Infirmary. The first fruit was my 1957 final year publication on the topographical analysis of 1000 cases of lung cancer autopsies; this appeared in the British Journal of Cancer. In turn, this led my Professor to draw glowing attention to it in a famous Textbook in 1958. Fortunately, my work blossomed, on account of fruitful safaris to the other Scottish Medical Schools. Thereafter, many publications on lymph-borne colonization patterns appeared. On the basis of them, let me conclude that the predictable orderliness of lymph-borne metastasis is indicative of the workings of an underlying intrinsic directional Factor. In sum, it may fittingly be named the “Lymphogenous Metastasis Selectivity Factor” (LMSF). Hence, it is hypothesized that its verification and identification could conduce to target therapy following breakthroughs in translational laboratories.